Literature DB >> 20635325

Investigation of polyethylenimine-grafted-triamcinolone acetonide as nucleus-targeting gene delivery systems.

Kun Ma1, Minxin Hu, Meng Xie, Haijun Shen, Liyan Qiu, Weimin Fan, Hongying Sun, Shuqing Chen, Yi Jin.   

Abstract

BACKGROUND: Nuclear membrane is one of the main barriers in polymer mediated intracellular gene delivery. To improve the transgenic activity and safety of nonviral vector, triamcinolone acetonide (TA) as a nuclear localization signal was conjugated with different molecular weight polyethylenimine (PEI).
METHODS: Different molecular weight PEI [600, 1800, 25,000 (25k)] was conjugated with TA to synthesize PEI-TA by two-step reaction. Their physicochemical characteristics, in vitro cytotoxicity and transfection efficiency were evaluated. To investigate the difference of transfection efficiency of various molecular weight PEI-TA, their transfection mechanism was further investigated by confocal microscopy and competition assay. Transgenic expression in vivo was evaluated by injection into hepatic portal vein of mice.
RESULTS: All PEI-TA could form nanosize polyplexes with DNA and their physicochemical properties resemble each other. Their cytotoxicities were negligible compared to PEI 25k. The order of transfection efficiency was PEI 1800-TA > PEI 600-TA > PEI 25k-TA. A transfection mechanism study displayed that TA could inhibit considerably the transgenic activity of PEI 1800-TA and PEI 600-TA, but that of PEI 25k-TA was not inhibited. It was suggested that PEI 1800-TA and PEI 600-TA might translocate into the nucleus. Confocal microscopy investigation verified this suggestion. The data strongly suggested that the transfection efficiency of PEI 1800-TA in vivo was much higher than that of PEI 25k, which was consistent with the results obtained in vitro.
CONCLUSIONS: Low molecular weight PEI-TA could translocate into the nucleus efficiently. PEI 1800-TA presented higher transgenic activity and it has a great potential for gene therapy as a nonviral carrier. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635325     DOI: 10.1002/jgm.1485

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  7 in total

1.  Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Authors:  Forrest M Kievit; Freddy Y Wang; Chen Fang; Hyejung Mok; Kui Wang; John R Silber; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

2.  Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells.

Authors:  Kun Ma; Duo Fu; Dongli Yu; Changhao Cui; Li Wang; Zhaoming Guo; Chuanbin Mao
Journal:  Biomaterials       Date:  2017-01-02       Impact factor: 12.479

3.  Development of a successive targeting liposome with multi-ligand for efficient targeting gene delivery.

Authors:  Kun Ma; Haijun Shen; Song Shen; Men Xie; Chuanbin Mao; Liyan Qiu; Yi Jin
Journal:  J Gene Med       Date:  2011-05       Impact factor: 4.565

4.  Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells.

Authors:  Panagiotis Mastorakos; Siva P Kambhampati; Manoj K Mishra; Tony Wu; Eric Song; Justin Hanes; Rangaramanujam M Kannan
Journal:  Nanoscale       Date:  2015-03-07       Impact factor: 7.790

Review 5.  Barriers to non-viral vector-mediated gene delivery in the nervous system.

Authors:  Francisco C Pérez-Martínez; Javier Guerra; Inmaculada Posadas; Valentín Ceña
Journal:  Pharm Res       Date:  2011-01-12       Impact factor: 4.200

6.  Synthesis, characterization and evaluation of transfection efficiency of dexamethasone conjugated poly(propyleneimine) nanocarriers for gene delivery#.

Authors:  Bizhan Malaekeh-Nikouei; Mehdi Rezaee; Leila Gholami; Naghmeh Sanjar Mousavi; Reza Kazemi Oskuee
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

Review 7.  Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects.

Authors:  Natallia V Dubashynskaya; Anton N Bokatyi; Yury A Skorik
Journal:  Biomedicines       Date:  2021-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.